APA (7th ed.) Citation

Peng, T., Liao, P., & Wu, T. (2023). Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis. Thoracic Cancer, 14(10), 929. https://doi.org/10.1111/1759-7714.14824

Chicago Style (17th ed.) Citation

Peng, Tzu‐Rong, Pei‐Fei Liao, and Ta‐Wei Wu. "Efficacy and Safety of Anaplastic Lymphoma Kinase Inhibitors for Non–small Cell Lung Cancer: A Systematic Review and Network Meta‐analysis." Thoracic Cancer 14, no. 10 (2023): 929. https://doi.org/10.1111/1759-7714.14824.

MLA (9th ed.) Citation

Peng, Tzu‐Rong, et al. "Efficacy and Safety of Anaplastic Lymphoma Kinase Inhibitors for Non–small Cell Lung Cancer: A Systematic Review and Network Meta‐analysis." Thoracic Cancer, vol. 14, no. 10, 2023, p. 929, https://doi.org/10.1111/1759-7714.14824.